London-based Timesulin, a smart replacement cap for insulin pens, announces the imminent launch of Timesulin into the United States following the recent success of a crowdfunding campaign on Indiegogo.
Timesulin has officially announced their U.S. launch in partnership with Facet Technologies at the annual American Association of Diabetes Educators in Orlando on August 6th, 2014. This news follows quick on the heels of their successful Indiegogo campaign, which raised funds and support to help fund the application process and move into the U.S. market.
Timesulin was co-founded by John Sjölund, who has lived with Type 1 diabetes for over 28 years. In a search to find a way to ease the anxiety of remembering when his last insulin shot was, he created Timesulin to solve a problem that wasn’t being addressed by any of the larger diabetes companies. The smart replacement cap is compatible with all major disposable insulin pens, and has an incorporated timer to show users how long it’s been since their last injection. This innovative technology helps significantly decrease the possibility of missed doses or accidental double insulin dose, which can cause serious complications.
“My colleagues and I have increasingly realized the power of simple solutions to support more balanced, safer lives with diabetes. Timesulin, along with Facet Technologies, has already developed and are continuing to develop new relevant, simple, powerful solutions that allow us to more easily and safely balance our lives with diabetes.”- Paul Madden, Sr. Director; Wellness, Diabetes/Noncommunicable Diseases, Global Health Project HOPE.
Launched in Europe in 2012, Timesulin is already available to the diabetes community on four continents and is excited to be able to offer the relief and peace of mind that Timesulin provides to the diabetes community in the U.S.
Timesulin will be joining forces with a leading US-based diabetes firm, Facet Technologies, which is the #1 supplier of lancets and lancing devices to the blood glucose monitoring market. Facet has been in the diabetes industry for over 40 years, working with the largest blood glucose monitoring companies. They are now launching a new consumer brand at AADE, CareFine, under the theme of providing simple solutions of comfort, quality, and affordability to help make diabetes management a little easier.
“We couldn’t be more excited about partnering with Timesulin to help improve the lives of people with diabetes in the U.S. Timesulin’s focus on making managing diabetes simpler makes them an ideal partner for Facet Technologies and the CareFine brand.” – Neil Luckianow, VP/General Manager Insulin Delivery – Facet Technologies.
Timesulin will be available shortly for online purchase, and will be available in select retail channels in the coming weeks.